◼ Archived
Health
🔮 fades ✓
CRISPR makes prostate cancer vulnerable to immunotherapy
CRISPR editing turns immune‑cold prostate tumors into immunotherapy targets, sparking a new treatment direction.
Immunotherapy
14 independently checked trend briefs about this subject, newest first.
What this Immunotherapy timeline shows
headlinez.news detected 14 source-qualified news clusters connected to Immunotherapy between June 23, 2026 and July 27, 2026. They span 1 newsroom category and average 5.9 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
◼ Archived
Health
🔮 fades ✓
Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy
Recent research links the thymus gland and its hormone, thymulin, to reduced age-related inflammation and improved cancer immunotherapy outcomes.
◼ Archived
Health
🔮 fades ✓
New stem cell approach targets functional cure for diabetes - News-Medical
Researchers are advancing a new cell therapy for Type 1 diabetes, utilizing immune-engineered cells to eliminate the need for immunosuppression.
◼ Archived
Health
🔮 fades ✗
Largest study yet reveals which cancers have their own microbiomes
Researchers are uncovering the link between tumor microbiomes and cancer treatment efficacy, marking a shift in how oncology approaches immunotherapy.
◼ Archived
Health
🔮 fades ✓
BCG vaccine linked to changes in brain immunity and Alzheimer's biomarkers
BCG vaccine linked to unexpected shifts in brain immunity and Alzheimer’s biomarkers—raising questions about its potential role in neurodegeneration.
◼ Archived
Health
🔮 fades ✗
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Researchers are highlighting a new immunotherapy approach targeting both glioblastoma cells and their supporting myeloid cells.
◼ Archived
Health
🔮 fades ✗
USC scientists just unlocked an endless supply of cancer-fighting immune cells
USC scientists have developed a new technique to enable the continuous self-renewal of immune cells used in cancer-fighting therapy.
◼ Archived
Health
🔮 fades ✓
New vitamin B12 therapy shows promise against deadly brain cancer
A new study indicates that vitamin B therapies may offer potential in the treatment of lethal brain cancers.
◼ Archived
Health
🔮 fades ✓
Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
Nature Medicine has retracted a high-profile study concerning the impact of treatment timing on PD-1 lung cancer therapy outcomes.
◼ Archived
Health
🔮 fades ✗
GABA Immune Pathway Drives Female Brain Cancer Growth
New research identifies a sex-specific GABA signaling pathway that facilitates glioblastoma progression in females.
◼ Archived
Health
🔮 fades ✗
Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks
A high-profile cancer therapy study has been retracted by Nature Medicine, prompting discussions regarding international research credibility.
◼ Archived
Health
🔮 fades ✓
A molecule called MHC I was understood for decades as the thing that lets the immune system recognize cancer, until researchers found the immune system attacks hardest exactly when cancer switches it off
Cancer’s immune-evasion trick just got exposed—and it could rewrite treatment strategies
◼ Archived
Health
🔮 fades ✗
A New Treatment for Gray Hair? Researchers Are Working on an Innovative Approach
Researchers are investigating immunotherapy techniques to potentially reverse gray hair following discoveries linked to cancer studies.
◼ Archived
Health
🔮 fades ✓
Two patients with severe autoimmune disease remain relapse-free for over 15 years after stem cell transplant
Two patients with severe autoimmune disease have remained free of relapses for over 15 years following a stem cell transplant.